Actively Recruiting

Age: 18Years +
All Genders
NCT06344143

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Led by The Cleveland Clinic · Updated on 2026-01-08

20

Participants Needed

1

Research Sites

318 weeks

Total Duration

On this page

Sponsors

T

The Cleveland Clinic

Lead Sponsor

R

RECORDATI GROUP

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma for prediction of the phenotype associated with cortisol excess. As well as following the patients for 4 years and see if anything changes.

CONDITIONS

Official Title

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients ages 18 years and older
  • Presence of adrenal incidentaloma confirmed by CT or MRI scan
  • 1-mg Dexamethasone suppression test cortisol level less than or equal to 5 µg/dL with adequate dexamethasone level
Not Eligible

You will not qualify if you...

  • 1-mg Dexamethasone suppression test cortisol level greater than 5 µg/dL with adequate dexamethasone level (indicating possible Cushing's syndrome)
  • Current or recent (within 3 months) use of glucocorticoid medications including steroid joint injections
  • History of uncontrolled hypertension or hypertension requiring more than 2 medications
  • History of uncontrolled type 2 diabetes mellitus or diabetes with A1c greater than 7.5
  • Known history of osteoporosis
  • Documented clinical Cushing's disease
  • Clinical suspicion of adrenal carcinoma
  • History of alcohol abuse or dependence
  • History of liver cirrhosis
  • History of hepatitis B or C infection
  • History of type 1 diabetes
  • History of hemochromatosis
  • History of autoimmune hepatitis
  • History of Wilson's disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

K

Kimberly Jenkins

CONTACT

A

Andrea Parianos

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here